Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
|
CN |
|
Shriram Asset Management Co Ltd
BSE:531359
|
IN |
|
Sona BLW Precision Forgings Ltd
NSE:SONACOMS
|
IN |
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
CN |
|
8
|
8990 Holdings Inc
XPHS:HOUSE
|
PH |
|
A
|
Anhui Anli Material Technology Co Ltd
SZSE:300218
|
CN |
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
D
|
Deer Consumer Products Inc
OTC:DEER
|
CN |
|
Prosperity Real Estate Investment Trust
HKEX:808
|
HK |
|
A
|
Advaxis Inc
OTC:ADXS
|
US |
Bankruptcy Probability
Guangdong VTR Bio-Tech Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Guangdong VTR Bio-Tech Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
|
3.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Guangdong VTR Bio-Tech Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Guangdong VTR Bio-Tech Co Ltd has total debt of 95.5m CNY. This includes both short-term (95.5m CNY) and long-term (0 CNY) debt.
You can find a full breakdown on its Balance Sheet.
